Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Starke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|March 21, 2007
The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpuraRichard Starke, Samuel Machin, Marie Scully, et al.
Transfusion|April 19, 2003
The majority of cellular prion protein released from endothelial cells is solubleRichard Starke, Paul Harrison, Olive Drummond, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 15, 2006
Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpuraMarie Scully, Richard Starke, Richard Lee, et al.
British Journal of Haematology|October 9, 2003
Endothelial cells express normal cellular prion proteinRichard Starke, Paul Harrison, Rosemary Gale, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
British Journal of Haematology|November 20, 2002
The expression of prion protein by endothelial cells: a source of the plasma form of prion protein?Richard Starke, Olive Drummond, Ian MacGregor, et al.
Thrombosis and Haemostasis|May 2, 2008
Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutationsCarolyn M Millar, Anne F Riddell, Simon A Brown, et al.
Journal of the Neurological Sciences|December 16, 2014
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic strokeDominick J H McCabe, Stephen J X Murphy, Richard Starke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 2015
Critical role of platelet glycoprotein ibα in arterial remodelingSue Chandraratne, Marie-Luise von Bruehl, Judith-Irina Pagel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|March 21, 2007
The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpuraRichard Starke, Samuel Machin, Marie Scully, et al.
Transfusion|April 19, 2003
The majority of cellular prion protein released from endothelial cells is solubleRichard Starke, Paul Harrison, Olive Drummond, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 15, 2006
Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpuraMarie Scully, Richard Starke, Richard Lee, et al.
British Journal of Haematology|October 9, 2003
Endothelial cells express normal cellular prion proteinRichard Starke, Paul Harrison, Rosemary Gale, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
British Journal of Haematology|November 20, 2002
The expression of prion protein by endothelial cells: a source of the plasma form of prion protein?Richard Starke, Olive Drummond, Ian MacGregor, et al.
Thrombosis and Haemostasis|May 2, 2008
Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutationsCarolyn M Millar, Anne F Riddell, Simon A Brown, et al.
Journal of the Neurological Sciences|December 16, 2014
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic strokeDominick J H McCabe, Stephen J X Murphy, Richard Starke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 2015
Critical role of platelet glycoprotein ibα in arterial remodelingSue Chandraratne, Marie-Luise von Bruehl, Judith-Irina Pagel, et al.
Pageof 1